73 results
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
10 May 24
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
7:05am
: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
25 Mar 24
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4:07pm
cellular therapeutics company focused on chronic kidney disease (CKD), today announced two recent strategic appointments enhancing the leadership team’s
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
21 Mar 24
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
8:00pm
Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD
8-K
EX-99.1
c2h3k ierw
26 Jan 24
Regulation FD Disclosure
12:00am
424B5
2cngs928nzzhhq6mzxt
19 Jan 24
Prospectus supplement for primary offering
4:16pm
S-3
t4wpzjd2fykjh
22 Nov 23
Shelf registration
9:22am
8-K
EX-99.1
afy7brjz
14 Nov 23
ProKidney Reports Third Quarter Financial Results
6:09am
8-K
EX-99.2
hoq3u5i0
13 Nov 23
Departure of Directors or Certain Officers
5:28pm
8-K
EX-99.1
24gzbbrx
13 Nov 23
Departure of Directors or Certain Officers
5:28pm
8-K
EX-99.1
dvdu1ou0
11 Sep 23
Regulation FD Disclosure
8:01am
424B3
dpac6ueh
22 Aug 23
Prospectus supplement
7:13pm
POS AM
9zjwh9ok
18 Aug 23
Prospectus update (post-effective amendment)
4:07pm
424B3
jpu 8q7gp1j8
11 Aug 23
Prospectus supplement
9:09am
8-K
EX-99.1
k12z21ukkbpnr0
10 Aug 23
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
4:33pm
424B3
n21 ffu0szex5nepoyk1
25 Jul 23
Prospectus supplement
4:06pm